Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer

Advanced gynecologic cancers have historically lacked effective treatment options. Recently, immune checkpoint inhibitors (ICIs) have been approved by the US Food and Drug Administration for the treatment of cervical cancer and endometrial cancer, offering durable responses for some patients. In add...

Descripción completa

Detalles Bibliográficos
Autores principales: Disis, Mary L, Adams, Sarah F, Bajpai, Jyoti, Butler, Marcus O, Curiel, Tyler, Dodt, Shelley A, Doherty, Laura, Emens, Leisha A, Friedman, Claire F, Gatti-Mays, Margaret, Geller, Melissa A, Jazaeri, Amir, John, Veena S, Kurnit, Katherine C, Liao, John B, Mahdi, Haider, Mills, Anne, Zsiros, Emese, Odunsi, Kunle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Position Article and Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277149/
https://www.ncbi.nlm.nih.gov/pubmed/37295818
http://dx.doi.org/10.1136/jitc-2022-006624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277149/
https://www.ncbi.nlm.nih.gov/pubmed/37295818
http://dx.doi.org/10.1136/jitc-2022-006624

Ejemplares similares